evidence/gaps
Cochrane · systematic review · CD007585

Lymphadenectomy for the management of endometrial cancer

Frost, JA, Webster, KE, Bryant, A, et al. · Cochrane Database of Systematic Reviews · 2017 · Cochrane Library

Gynaecological, Neuro-oncology and Orphan Cancer3 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
5
current version
GRADE rated
5
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 4 · 80%High 1 · 20%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Show all 3 versions

Summary of findings table

Population: women with stage I endometrial cancer
5 questions
OutcomeEffectEvidenceStatus / GRADE
Overall survival
HR 1.07 [0.81, 1.43]2 studies · 1851 participantsModerate
Downgraded: imprecision
Recurrence‐free survival
HR 1.23 [0.96, 1.58]2 studies · 1851 participantsModerate
Downgraded: imprecision
Direct surgical morbidity
RR 1.93 [0.79, 4.71]2 studies · 1922 participantsModerate
Downgraded: imprecision
Surgery‐related systemic morbidity
RR 3.72 [1.04, 13.27]2 studies · 1922 participantsModerate
Downgraded: imprecision
Lymphoedema or lymphocyst
RR 8.39 [4.06, 17.33]2 studies · 1922 participantsHigh